Phyllis Arthur's Testimony to Senate HELP Committee on Lessons Learned from Covid-19
July 27, 2021
COVID-19 will not be our last public health emergency. We face numerous bio-threats from natural and bioterror threats. Strong support for medical countermeasures R&D is critical to protecting our national security.
Today I will share BIO’s thoughts on how to strengthen our national preparedness through coordinated leadership, expanded partnership with industry and better public health infrastructure.
One thing that we can all agree on is the need to give our children a fighting chance so they can lead long and productive lives. That is why it is critical to pass the bipartisan Give Kids a Chance Act and ensure the Pediatric Priority Review…
Dear Colleagues, This month marks my one-year anniversary as BIO's CEO. Like most of us in biotech, this post has been a labor of love. At no time in my 25-year career in this industry have I ever witnessed such awe-inspiring science. Today, we…
Re: BIO Comments on Office of Management and Budget (OMB) Statistical Policy Directive No. 8 North American Industry Classification System (NAICS)-Request for Comments on Possible Revisions for 2027 (USBC–2024–0032)Dear Ms. Orvis,The Biotechnology…
COVID-19 will not be our last public health emergency. We face numerous bio-threats from natural and bioterror threats. Strong support for medical countermeasures R&D is critical to protecting our national security.
Today I will share BIO’s thoughts on how to strengthen our national preparedness through coordinated leadership, expanded partnership with industry and better public health infrastructure.